Effect of Evolocumab on Vascular Function

NCT03626831 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease

Interventions

DRUG: Evolocumab Prefilled Syringe
DRUG: Placebos

Sponsor

University of Erlangen-Nürnberg Medical School